NorthStar Asset Management (Pennsylvania)’s Novo Nordisk NVO Stock Holding History

NorthStar Asset Management (Pennsylvania)’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$919K	Buy	+18,853	New	+$810K	0.17%	72
2013 Q3	–	Sell	-100,000	Closed	-$1.55M	–	101
2013 Q2	$1.55M	Buy	+100,000	New	+$1.66M	0.66%	44

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

NorthStar Asset Management (Pennsylvania)'s NVO Position: Q2 2026 in Review

NorthStar Asset Management (Pennsylvania) opened a new position in Novo Nordisk (NVO) in Q2 2026: 18,853 shares worth $919K. The stake represents 0.17% of the portfolio and ranks #72 among its holdings. This is a return to the name: NorthStar Asset Management (Pennsylvania) previously reported a position in NVO as recently as Q2 2013.

NorthStar Asset Management (Pennsylvania) first reported a position in NVO in Q2 2013 and has held it in 2 quarters since. The position peaked at $1.55M in Q2 2013. 1,358 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

NorthStar Asset Management (Pennsylvania) held 18,853 shares of Novo Nordisk worth $919K as of Q2 2026.
Novo Nordisk was a new NorthStar Asset Management (Pennsylvania) position in Q2 2026.
Novo Nordisk made up 0.17% of NorthStar Asset Management (Pennsylvania)'s portfolio in Q2 2026, its #72 holding.
NorthStar Asset Management (Pennsylvania) first reported a position in Novo Nordisk in Q2 2013 and has held it in 2 quarters since.
NorthStar Asset Management (Pennsylvania)'s Novo Nordisk position peaked at $1.55M in Q2 2013.
1,358 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q2 2026, filed 27 Jul 2026.